CDH17 and carcinoma: E-Cadherin and N-Cadherin, the most dominant cadherins expressed in carcinomas significantly contribute to metastasis [32, 33], and has been known to suppress Wnt/β-Catenin pathway activation through sequestration of β-Catenin to the cell membrane [34, 35].